Select Page

Researchers at the Indian Institute of Technology (IIT), Madras, have made a significant breakthrough in breast cancer treatment with a newly patented next-generation drug delivery system. This innovative system uses nanomaterials to target cancerous cells precisely, offering a safer and more effective alternative to traditional chemotherapy. Unlike conventional treatments, the nanocarriers are biocompatible, avoiding toxic side effects like hair loss and immune suppression. Lab tests have shown promising results, effectively halting tumor growth in breast cancer cells. The researchers aim to transition to animal model testing and collaborate with healthcare industries to bring this technology to clinical trials, potentially transforming cancer therapy globally. This advancement has the potential to enhance treatment efficacy and minimize the risks associated with traditional chemotherapy.

Read the Full Article